| SCs | Synthetic cannabinoids |
| NPS | New psychoactive substances |
| CB1 | Cannabinoid receptor type 1 |
| THC | Δ9-tetrahydrocannabinol |
| HLM | Human liver microsomes |
| CYP450 | Cytochrome P450 enzyme family |
| UHPLC | Ultra-high-performance liquid chromatography |
| UHPLC–QE Orbitrap–MS | Ultra-high-performance liquid chromatography–Q Exactive Orbitrap mass spectrometry |
| LC–MS | Liquid chromatography–mass spectrometry |
| HRMS | High-resolution mass spectrometry |
| MS/MS | Tandem mass spectrometry |
| MS2 | Secondary mass spectrometry |
| MS1 | Precursor ion full-scan mass spectrometry |
| NCE | Normalized collision energy |
| AGC | Automatic gain control |
| IT | Injection time |
| m/z | Mass-to-charge ratio |
| ppm | Parts per million |
| ESI | Electrospray ionization |
| PBS | Phosphate-buffered saline |
| FA | Formic acid |
| ACN | Acetonitrile |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| AUs | Arbitrary units |